| scholarly article | Q13442814 |
| P50 | author | Cory M Hogaboam | Q61079289 |
| P2093 | author name string | Zenebech Wondimu | |
| Mark G Swain | |||
| Amanda E I Proudfoot | |||
| Maureen N Ajuebor | |||
| Tai Le | |||
| P2860 | cites work | Selective diapedesis of Th1 cells induced by endothelial cell RANTES | Q22010520 |
| Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene | Q29614892 | ||
| Trafficking of natural killer cells | Q30434420 | ||
| The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. | Q31725223 | ||
| Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. | Q33540290 | ||
| Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis | Q33902443 | ||
| NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells | Q33946628 | ||
| NK cells and NKT cells in innate defense against viral infections | Q34332682 | ||
| CCR5 in T cell-mediated liver diseases: what's going on? | Q34554132 | ||
| The role of NK cells in autoimmune disease | Q34573943 | ||
| Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. | Q34826141 | ||
| Hepatic T cells and liver tolerance | Q35038298 | ||
| Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. | Q35056090 | ||
| A T cell-dependent experimental liver injury in mice inducible by concanavalin A | Q35603939 | ||
| CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver | Q80565321 | ||
| Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1 | Q81089017 | ||
| CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice | Q81242894 | ||
| Autoimmune liver disease | Q81386388 | ||
| Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism | Q81535584 | ||
| TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver | Q82323207 | ||
| Importance of Kupffer cells for T-cell-dependent liver injury in mice | Q35829575 | ||
| NK cells in innate immunity | Q36010994 | ||
| Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response | Q36011955 | ||
| NK cells: elusive players in autoimmunity | Q36238861 | ||
| NK cells in autoimmune disease. | Q36329077 | ||
| T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. | Q36363056 | ||
| Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways | Q36381040 | ||
| CD95L/FasL and TRAIL in tumour surveillance and cancer therapy. | Q36446775 | ||
| Missing self recognition and self tolerance of natural killer (NK) cells | Q36494742 | ||
| Critical contribution of liver natural killer T cells to a murine model of hepatitis | Q36979591 | ||
| Critical roles of TRAIL in hepatic cell death and hepatic inflammation. | Q40364687 | ||
| Essential role of the adhesion receptor LFA-1 for T cell-dependent fulminant hepatitis | Q40684750 | ||
| Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. | Q41814635 | ||
| Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis | Q42157047 | ||
| IL-4 induces in vivo production of IFN-gamma by NK and NKT cells | Q42493470 | ||
| NK cell functions restrain T cell responses during viral infections | Q43760321 | ||
| Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis | Q44701472 | ||
| NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice | Q44772788 | ||
| Involvement of natural killer cells in PolyI:C-induced liver injury | Q45175705 | ||
| High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1. | Q45858918 | ||
| IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors | Q46391158 | ||
| Trials of aplaviroc halted in treatment-naive patients | Q46831992 | ||
| IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. | Q47216670 | ||
| CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis. | Q47293732 | ||
| Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. | Q52039136 | ||
| Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. | Q52551745 | ||
| C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. | Q53767913 | ||
| Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. | Q53855176 | ||
| Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene | Q56591978 | ||
| What can stochastic resonance do? | Q59061953 | ||
| Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells | Q59387569 | ||
| Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide | Q60489559 | ||
| A chemokine receptor antagonist inhibits experimental breast tumor growth | Q61819228 | ||
| Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis | Q71173415 | ||
| Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A | Q71215744 | ||
| Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism | Q72996711 | ||
| Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells | Q73098737 | ||
| Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation | Q73114534 | ||
| Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice | Q73535883 | ||
| Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets | Q73910691 | ||
| Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18 | Q74108232 | ||
| Potential roles for chemokine receptor CCR5 in the pathobiology of hepatitis C infection | Q74262599 | ||
| Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice | Q74477596 | ||
| RNA interference targeting Fas protects mice from fulminant hepatitis | Q78961966 | ||
| CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis | Q80386418 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1975-1988 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis | |
| P478 | volume | 170 |
| Q39639458 | Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice |
| Q84459514 | Anti-chemokine therapy for the treatment of hepatic fibrosis: an attractive approach |
| Q26786188 | Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research |
| Q41595129 | Biological and Structural Characterization of Rotamers of C-C Chemokine Receptor Type 5 (CCR5) Inhibitor GSK214096. |
| Q42705850 | CCR5 knockout mice with C57BL6 background are resistant to acetaminophen-mediated hepatotoxicity due to decreased macrophages migration into the liver |
| Q42924000 | CGX, a traditional Korean medicine ameliorates concanavalin A-induced acute liver injury |
| Q52605836 | Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis. |
| Q64375899 | Characterization of the role of TCR gammadelta in NK cell accumulation during viral liver inflammation |
| Q37345875 | Chemokine-directed immune cell infiltration in acute and chronic liver disease |
| Q34761117 | Circulating herpes simplex type 1 (HSV-1)-specific CD8+ T cells do not access HSV-1 latently infected trigeminal ganglia. |
| Q64280207 | Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity |
| Q41071492 | Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury |
| Q37723178 | Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases |
| Q33604746 | Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis |
| Q37803119 | Functional role of chemokines in liver disease models |
| Q30439944 | GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk |
| Q28260051 | Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice |
| Q27487445 | Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus |
| Q36224997 | Impact of NKT Cells and LFA-1 on Liver Regeneration under Subseptic Conditions |
| Q33722663 | Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors A/B and/or C-C Chemokine Receptors 2/5 Inhibit Vascular Injury Response |
| Q37207091 | Inflammatory pathways in liver homeostasis and liver injury |
| Q37115634 | Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B. |
| Q28730116 | Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury |
| Q39171809 | Microfluidic-based, live-cell analysis allows assessment of NK-cell migration in response to crosstalk with dendritic cells |
| Q83179770 | Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice |
| Q46927225 | Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor |
| Q43565423 | Polymorphisms of CCL3L1/CCR5 genes and recurrence of hepatitis B in liver transplant recipients |
| Q34254438 | Protective Role of Interleukin-17 in Murine NKT Cell-Driven Acute Experimental Hepatitis |
| Q38148785 | Targeting CCL5 in inflammation |
| Q34305284 | The ROS scavenger, NAC, regulates hepatic Vα14iNKT cells signaling during Fas mAb-dependent fulminant liver failure |
| Q45906020 | The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. |
| Q34994967 | The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer. |
| Q61443001 | The potential risks of C-C chemokine receptor 5-edited babies in bone development |
| Q51042074 | The regulation of T-cell recruitment to the human liver during acute liver failure. |
| Q42208932 | The role of chemokines in acute liver injury |
| Q38197441 | The role of chemokines in hepatitis C virus-mediated liver disease |
| Q37960533 | Therapeutic potential of chemokine receptor antagonists for liver disease |
| Q30432794 | Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells |
| Q42619067 | Two structurally identical mannose-specific jacalin-related lectins display different effects on human T lymphocyte activation and cell death. |
| Q30433085 | V(alpha)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy |
Search more.